Pfizer Says COVID-19 Vaccine More Than 90% Effective In Children Aged 5-11
NDTV
Overall, 158 children aged 5 to 11 have died from Covid in the United States since the start of the pandemic, according to official data.
Pfizer's Covid-19 vaccine is more than 90 percent effective in preventing symptomatic disease among children aged 5-to-11, the company said in a document released Friday that put forward its case for authorization.
The new data was published on the website of the Food and Drug Administration, which has called an advisory panel of independent experts to meet Tuesday to vote on whether to green light the shot.
The analysis was based on around 2,250 trial participants, randomized to receive either the vaccine or a placebo, with data accruing until October 8. Most positive cases occurred when the Delta variant was dominant in the US and globally.
"VE (Vaccine Efficacy) against laboratory-confirmed symptomatic Covid-19 occurring at least 7 days after Dose 2 in evaluable participants without evidence of prior SARS-CoV-2 infection was 90.7%," the document said.
